Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Arterioscler Thromb Vasc Biol ; 42(4): e96-e114, 2022 04.
Article in English | MEDLINE | ID: mdl-35139658

ABSTRACT

BACKGROUND: Vascular pericytes stabilize blood vessels and contribute to their maturation, while playing other key roles in microvascular function. Nevertheless, relatively little is known about involvement of their precursors in the earliest stages of vascular development, specifically during vasculogenesis. METHODS: We combined high-power, time-lapse imaging with transcriptional profiling of emerging pericytes and endothelial cells in reporter mouse and cell lines. We also analyzed conditional transgenic animals deficient in Cx43/Gja1 (connexin 43/gap junction alpha-1) expression within Ng2+ cells. RESULTS: A subset of Ng2-DsRed+ cells, likely pericyte/mural cell precursors, arose alongside endothelial cell differentiation and organization and physically engaged vasculogenic endothelium in vivo and in vitro. We found no overlap between this population of differentiating pericyte/mural progenitors and other lineages including hemangiogenic and neuronal/glial cell types. We also observed cell-cell coupling and identified Cx43-based gap junctions contributing to pericyte-endothelial cell precursor communication during vascular assembly. Genetic loss of Cx43/Gja1 in Ng2+ pericyte progenitors compromised embryonic blood vessel formation in a subset of animals, while surviving mutants displayed little-to-no vessel abnormalities, suggesting a resilience to Cx43/Gja1 loss in Ng2+ cells or potential compensation by additional connexin isoforms. CONCLUSIONS: Together, our data suggest that a distinct pericyte lineage emerges alongside vasculogenesis and directly communicates with the nascent endothelium via Cx43 during early vessel formation. Cx43/Gja1 loss in pericyte/mural cell progenitors can induce embryonic vessel dysmorphogenesis, but alternate connexin isoforms may be able to compensate. These data provide insight that may reshape the current framework of vascular development and may also inform tissue revascularization/vascularization strategies.


Subject(s)
Connexin 43 , Pericytes , Animals , Cell Differentiation , Connexin 43/genetics , Connexins/genetics , Endothelial Cells , Mice
2.
PLoS One ; 14(10): e0223842, 2019.
Article in English | MEDLINE | ID: mdl-31622977

ABSTRACT

The process by which fibroblasts are directly reprogrammed into cardiomyocytes involves two stages; initiation and maturation. Initiation represents the initial expression of factors that induce fibroblasts to transdifferentiate into cardiomyocytes. Following initiation, the cell undergoes a period of maturation before becoming a mature cardiomyocyte. We wanted to understand the role of cardiac development transcription factors in the maturation process. We directly reprogram fibroblasts into cardiomyocytes by a combination of miRNAs (miR combo). The ability of miR combo to induce cardiomyocyte-specific genes in fibroblasts was lost following the knockdown of the cardiac transcription factors Gata4, Mef2C, Tbx5 and Hand2 (GMTH). To further clarify the role of GMTH in miR combo reprogramming we utilized a modified CRISPR-Cas9 approach to activate endogenous GMTH genes. Importantly, both miR combo and the modified CRISPR-Cas9 approach induced comparable levels of GMTH expression. While miR combo was able to reprogram fibroblasts into cardiomyocyte-like cells, the modified CRISPR-Cas9 approach could not. Indeed, we found that cardiomyocyte maturation only occurred with very high levels of GMT expression. Taken together, our data indicates that while endogenous cardiac transcription factors are insufficient to reprogram fibroblasts into mature cardiomyocytes, endogenous cardiac transcription factors are necessary for expression of maturation genes.


Subject(s)
GATA4 Transcription Factor/genetics , T-Box Domain Proteins/genetics , Animals , CRISPR-Cas Systems/genetics , Cell Transdifferentiation , Cells, Cultured , Cellular Reprogramming , Fibroblasts/cytology , Fibroblasts/metabolism , GATA4 Transcription Factor/antagonists & inhibitors , GATA4 Transcription Factor/metabolism , Gene Editing , MEF2 Transcription Factors/antagonists & inhibitors , MEF2 Transcription Factors/genetics , MEF2 Transcription Factors/metabolism , Mice , Mice, Inbred C57BL , Myocytes, Cardiac/cytology , Myocytes, Cardiac/metabolism , RNA Interference , RNA, Small Interfering/metabolism , T-Box Domain Proteins/antagonists & inhibitors , T-Box Domain Proteins/metabolism
3.
Stem Cells ; 36(8): 1198-1209, 2018 08.
Article in English | MEDLINE | ID: mdl-29676038

ABSTRACT

The process by which committed precursors mature into cardiomyocytes is poorly understood. We found that TLR3 inhibition blocked cardiomyocyte maturation; precursor cells committed to the cardiomyocyte lineage failed to express maturation genes and sarcomeres did not develop. Using various approaches, we found that the effects of TLR3 upon cardiomyocyte maturation were dependent upon the RelA subunit of nuclear factor kappa B (NFκB). Importantly, under conditions that promote the development of mature cardiomyocytes NFκB became significantly enriched at the promoters of cardiomyocyte maturation genes. Furthermore, activation of the TLR3-NFκB pathway enhanced cardiomyocyte maturation. This study, therefore, demonstrates that the TLR3-NFκB pathway is necessary for the maturation of committed precursors into mature cardiomyocytes. Stem Cells 2018;36:1198-1209.


Subject(s)
Cell Differentiation , Myocytes, Cardiac/cytology , Myocytes, Cardiac/metabolism , NF-kappa B/metabolism , Toll-Like Receptor 3/metabolism , Animals , Animals, Newborn , Cellular Reprogramming , Fibroblasts/cytology , Fibroblasts/metabolism , Gene Expression Regulation , Mice, Inbred C57BL , MicroRNAs/genetics , MicroRNAs/metabolism , Promoter Regions, Genetic/genetics , Protein Subunits/metabolism , Toll-Like Receptor 3/antagonists & inhibitors , Transcription Factor RelA/metabolism
4.
Circ Res ; 120(9): 1403-1413, 2017 Apr 28.
Article in English | MEDLINE | ID: mdl-28209718

ABSTRACT

RATIONALE: Direct reprogramming of cardiac fibroblasts to cardiomyocytes has recently emerged as a novel and promising approach to regenerate the injured myocardium. We have previously demonstrated the feasibility of this approach in vitro and in vivo using a combination of 4 microRNAs (miR-1, miR-133, miR-208, and miR-499) that we named miR combo. However, the mechanism of miR combo mediated direct cardiac reprogramming is currently unknown. OBJECTIVE: Here, we investigated the possibility that miR combo initiated direct cardiac reprogramming through an epigenetic mechanism. METHODS AND RESULTS: Using a quantitative polymerase chain reaction array, we found that histone methyltransferases and demethylases that regulate the trimethylation of H3K27 (H3K27me3), an epigenetic modification that marks transcriptional repression, were changed in miR combo-treated fibroblasts. Accordingly, global H3K27me3 levels were downregulated by miR combo treatment. In particular, the promoter region of cardiac transcription factors showed decreased H3K27me3 as revealed by chromatin immunoprecipitation coupled with quantitative polymerase chain reaction. Inhibition of H3K27 methyltransferases or of the PRC2 (Polycomb Repressive Complex 2) by pharmaceutical inhibition or siRNA reduced the levels of H3K27me3 and induced cardiogenic markers at the RNA and protein level, similarly to miR combo treatment. In contrast, knockdown of the H3K27 demethylases Kdm6A and Kdm6B restored the levels of H3K27me3 and blocked the induction of cardiac gene expression in miR combo-treated fibroblasts. CONCLUSIONS: In summary, we demonstrated that removal of the repressive mark H3K27me3 is essential for the induction of cardiac reprogramming by miR combo. Our data not only highlight the importance of regulating the epigenetic landscape during cell fate conversion but also provide a framework to improve this technique.


Subject(s)
Cellular Reprogramming , DNA Methylation , Epigenesis, Genetic , Fibroblasts/metabolism , Histones/metabolism , MicroRNAs/metabolism , Myocytes, Cardiac/metabolism , Animals , Animals, Newborn , Cellular Reprogramming/drug effects , Cellular Reprogramming Techniques , DNA Methylation/drug effects , Enzyme Inhibitors/pharmacology , Epigenesis, Genetic/drug effects , Fibroblasts/drug effects , Gene Expression Regulation , HEK293 Cells , Histone Demethylases/genetics , Histone Demethylases/metabolism , Histones/genetics , Humans , Jumonji Domain-Containing Histone Demethylases/antagonists & inhibitors , Jumonji Domain-Containing Histone Demethylases/genetics , Jumonji Domain-Containing Histone Demethylases/metabolism , Methylation , Mice, Inbred C57BL , MicroRNAs/genetics , Myocytes, Cardiac/drug effects , Polycomb Repressive Complex 2/genetics , Polycomb Repressive Complex 2/metabolism , RNA Interference , Signal Transduction , Transfection
5.
Sci Rep ; 6: 38815, 2016 12 12.
Article in English | MEDLINE | ID: mdl-27941896

ABSTRACT

We have recently shown that a combination of microRNAs, miR combo, can directly reprogram cardiac fibroblasts into functional cardiomyocytes in vitro and in vivo. Reprogramming of cardiac fibroblasts by miR combo in vivo is associated with improved cardiac function following myocardial infarction. However, the efficiency of direct reprogramming in vitro is relatively modest and new strategies beyond the traditional two-dimensional (2D) culture should be identified to improve reprogramming process. Here, we report that a tissue-engineered three-dimensional (3D) hydrogel environment enhanced miR combo reprogramming of neonatal cardiac and tail-tip fibroblasts. This was associated with significantly increased MMPs expression in 3D vs. 2D cultured cells, while pharmacological inhibition of MMPs blocked the effect of the 3D culture on enhanced miR combo mediated reprogramming. We conclude that 3D tissue-engineered environment can enhance the direct reprogramming of fibroblasts to cardiomyocytes via a MMP-dependent mechanism.


Subject(s)
Cellular Microenvironment/physiology , Cellular Reprogramming/drug effects , Fibroblasts/drug effects , MicroRNAs/pharmacology , Myocytes, Cardiac/cytology , Tissue Engineering/methods , Animals , Animals, Newborn , Cells, Cultured , Cellular Reprogramming/physiology , Fibroblasts/cytology , Gene Expression Regulation, Developmental/drug effects , Genes, Reporter , Hydrogels , Mice , MicroRNAs/genetics , Muscle Proteins/biosynthesis , Muscle Proteins/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Transcription Factors/biosynthesis , Transcription Factors/genetics , Transfection
6.
Circ Res ; 116(10): 1700-11, 2015 May 08.
Article in English | MEDLINE | ID: mdl-25953925

ABSTRACT

The human heart has a limited capacity to regenerate lost or damaged cardiomyocytes after cardiac insult. Instead, myocardial injury is characterized by extensive cardiac remodeling by fibroblasts, resulting in the eventual deterioration of cardiac structure and function. Cardiac function would be improved if these fibroblasts could be converted into cardiomyocytes. MicroRNAs (miRNAs), small noncoding RNAs that promote mRNA degradation and inhibit mRNA translation, have been shown to be important in cardiac development. Using this information, various researchers have used miRNAs to promote the formation of cardiomyocytes through several approaches. Several miRNAs acting in combination promote the direct conversion of cardiac fibroblasts into cardiomyocytes. Moreover, several miRNAs have been identified that aid the formation of inducible pluripotent stem cells and miRNAs also induce these cells to adopt a cardiac fate. MiRNAs have also been implicated in resident cardiac progenitor cell differentiation. In this review, we discuss the current literature as it pertains to these processes, as well as discussing the therapeutic implications of these findings.


Subject(s)
Heart Diseases/metabolism , MicroRNAs/metabolism , Myocytes, Cardiac/metabolism , Regeneration , Animals , Cell Lineage , Cell Transdifferentiation , Cellular Reprogramming , Fibroblasts/metabolism , Fibroblasts/pathology , Gene Expression Regulation , Heart Diseases/genetics , Heart Diseases/pathology , Heart Diseases/physiopathology , Humans , MicroRNAs/genetics , Myocytes, Cardiac/pathology , Phenotype , Signal Transduction , Stem Cells/metabolism , Stem Cells/pathology
7.
Circ Res ; 115(12): 1007-16, 2014 Dec 05.
Article in English | MEDLINE | ID: mdl-25296984

ABSTRACT

RATIONALE: Cardiac progenitor cells (CPCs) are thought to differentiate into the major cell types of the heart: cardiomyocytes, smooth muscle cells, and endothelial cells. We have recently identified ABI family, member 3 (NESH) binding protein (Abi3bp) as a protein important for mesenchymal stem cell biology. Because CPCs share several characteristics with mesenchymal stem cells, we hypothesized that Abi3bp would similarly affect CPC differentiation and proliferation. OBJECTIVE: To determine whether Abi3bp regulates CPC proliferation and differentiation. METHODS AND RESULTS: In vivo, genetic ablation of the Abi3bp gene inhibited CPC differentiation, whereas CPC number and proliferative capacity were increased. This correlated with adverse recovery after myocardial infarction. In vitro, CPCs, either isolated from Abi3bp knockout mice or expressing an Abi3bp shRNA construct, displayed a higher proliferative capacity and, under differentiating conditions, reduced expression of both early and late cardiomyocyte markers. Abi3bp controlled CPC differentiation via integrin-ß1, protein kinase C-ζ, and v-akt murine thymoma viral oncogene homolog. CONCLUSIONS: We have identified Abi3bp as a protein important for CPC differentiation and proliferation.


Subject(s)
Carrier Proteins/metabolism , Cell Differentiation , Cell Proliferation , Mesenchymal Stem Cells/metabolism , Myocardial Infarction/metabolism , Myocytes, Cardiac/metabolism , Animals , Carrier Proteins/genetics , Cells, Cultured , Disease Models, Animal , Integrin beta1/metabolism , Isoenzymes/metabolism , Male , Mesenchymal Stem Cells/pathology , Mice, Knockout , Myocardial Contraction , Myocardial Infarction/genetics , Myocardial Infarction/pathology , Myocardial Infarction/physiopathology , Myocytes, Cardiac/pathology , Protein Kinase C/metabolism , Protein Kinase C-theta , Proto-Oncogene Proteins c-akt/metabolism , RNA Interference , Recovery of Function , Regeneration , Signal Transduction , Stroke Volume , Time Factors , Transfection
8.
Curr Treat Options Cardiovasc Med ; 16(8): 327, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24928147

ABSTRACT

OPINION STATEMENT: Reconstitution of cardiac muscle as well as blood vessels to provide sufficient oxygenation and nutrients to the myocardium is an important component of any therapeutic approach for cardiac repair after injury. Recent reports of reprogramming somatic cells directly to cells of another lineage raised the possibility of using cell reprogramming for cardiac regenerative therapy. Here, we provide an overview of the current reprogramming strategies to generate cardiomyocytes (CMs), endothelial cells (ECs) and smooth muscle cells (SMCs), and the implications of these methods for cardiac regeneration. We also discuss the challenges and limitations that need to be addressed for the development of future therapies.

9.
Dev Biol ; 350(2): 484-95, 2011 Feb 15.
Article in English | MEDLINE | ID: mdl-21172337

ABSTRACT

In vertebrates, embryonic structures present at the dorsal midline, prechordal plate, notochord, hypochord and floor plate share a common embryonic origin. In zebrafish, they derive from a pool of progenitors located within the embryonic shield at the onset of gastrulation. The molecular mechanisms responsible for the common development of these structures remain unknown. Based on their spatial and temporal expression, transcription factors of the Forkhead box A (FoxA) family appeared to be good candidates to play such a role. In agreement with this hypothesis, we found that simultaneous knockdown of FoxA2 and FoxA3 abolish the formation of all axial derivatives, while overexpression of these transcription factors strongly enlarges dorsal mesodermal territories. We establish that, in FoxA2-FoxA3 double morphants, precursors of axial tissues are correctly induced at early gastrula stage, but their dorsal midline identity is not maintained during development and we found that progenitors of these tissues are cell-autonomously re-specified to form muscle fibers as well as cells of the ventral neural tube. Our study provides the first example of a specific loss of all dorsal midline tissues and demonstrates that members of the FoxA family have redundant functions essential to maintain the axial identity of prechordal plate, notochord, floor plate and hypochord progenitors during gastrulation.


Subject(s)
Forkhead Transcription Factors/physiology , Hepatocyte Nuclear Factor 3-gamma/physiology , Zebrafish Proteins/physiology , Zebrafish/embryology , Animals , Gastrulation , Mesoderm/physiology
10.
Dev Biol ; 298(2): 514-26, 2006 Oct 15.
Article in English | MEDLINE | ID: mdl-16890217

ABSTRACT

In Xenopus, the dorso-ventral (D/V) axis is thought to be specified by the bone morphogenetic proteins (Bmp) activity arising through interaction with antagonists such as Noggin, Chordin and Follistatin. We report here, through inactivation of noggin1 (nog1) that this gene is not essential by itself to establish the D/V patterning. However, at blastula stage, inactivation of nog1 strongly amplifies chordin (chd) phenotype, revealing redundant functions of these two genes on D/V axis formation. Substantial dorsal tissues remaining in the double nog1-chd morphant suggested that other anti-Bmp factors may pattern the D/V axis. We isolated two potential candidates, the follistatin-like (fstl) genes. We found that fstl2 is an early gastrula expressed gene. Its inactivation, similar to nog1, strongly enhances the chd phenotype. Moreover, the penetrance of the ventralization phenotype is much higher when we inactivated simultaneously chd, nog1 and fstl2. Altogether, our data reveal that, while Chordin is the main player of the D/V axis, sufficient to maintain proper activity of Bmp gradient, the structures remaining in the chd mutant (namely dorsal and dorso-lateral territories, in both mesodermal and ectodermal layers) result from the anti-Bmp activity carried by Nog1 and Fstl2 at blastula and gastrula stages.


Subject(s)
Body Patterning , Bone Morphogenetic Proteins/physiology , Carrier Proteins/physiology , Follistatin-Related Proteins/physiology , Glycoproteins/physiology , Intercellular Signaling Peptides and Proteins/physiology , Zebrafish Proteins/physiology , Zebrafish/embryology , Animals , Base Sequence , Bone Morphogenetic Proteins/antagonists & inhibitors , Carrier Proteins/genetics , Embryo, Nonmammalian , Follistatin/genetics , Gene Expression Regulation, Developmental , Glycoproteins/genetics , Intercellular Signaling Peptides and Proteins/genetics , Molecular Sequence Data , RNA/genetics , Zebrafish Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...